Terry Braun
Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
BACKGROUND Autosomal dominant non-syndromic hearing loss (ADNSHL) is highly heterogeneous, with more than 64 genes implicated in its etiology. This complexity limits the diagnostic power of clinical examinations and audiometry alone, while existing computational approaches have achieved only moderate accuracy and often lack interpretability. As precision medicine increasingly emphasizes genotype-phenotype correlations, there is a pressing need for diagnostic tools that provide clinicians with transparent, interpretable outputs. OBJECTIVE This study aimed to develop and evaluate the AudioGene Translational Dashboard (AGTD), an interpretable clinical informatics tool that integrates machine learning models and interactive visualizations to enhance genotype–phenotype correlation and support diagnostic decision-making in autosomal dominant non-syndromic hearing loss (ADNSHL). METHODS We developed the AGTD, integrating two sophisticated machine learning models (AG4 and AG9.1) with six interactive visualization tools. AG4 utilizes a multi-instance support vector machine classifier for patients with multiple audiograms, while AG9.1 combines adaptive boosting, k-nearest neighbors, random forest models, and logistic regression for patients with a single audiogram. Visualizations include audiometric profile plots, Audioprofile surfaces, clustering analyses, and data distribution charts designed to facilitate clinical interpretation. RESULTS AGTD introduced the ‘70/30’ rule, indicating a 74% likelihood that the causative gene is among the top three predicted genes, thereby providing clinicians a clear confidence indicator ('green flag') or caution alert ('red flag') during diagnosis. Visualization tools significantly enhanced clinicians' ability to interpret and correlate phenotypic data with predicted genetic outcomes, improving diagnostic confidence and interpretability. CONCLUSIONS The AGTD significantly advances clinical informatics in genetic diagnostics of ADNSHL by integrating explainable AI and interactive visualizations, enhancing clinical interpretability and diagnostic accuracy. This approach facilitates informed clinical decision-making, highlights the translational potential of genotype-phenotype computational models, and supports precision medicine in hearing loss diagnostics. Future enhancements will target improving class balance and incorporating additional user-customizable features to further optimize clinical applicability.
Year:
2025
The COVID-19 pandemic has caused substantial worldwide disruptions in health, economy, and society, manifesting symptoms such as loss of smell (anosmia) and loss of taste (ageusia), that can result in prolonged sensory impairment. Establishing the host genetic etiology of anosmia and ageusia in COVID-19 will aid in the overall understanding of the sensorineural aspect of the disease and contribute to possible treatments or cures. By using human genome sequencing data from the University of Iowa (UI) COVID-19 cohort (N=187) and the National Institute of Health All of Us (AoU) Research Program COVID-19 cohort (N=947), we investigated the genetics of anosmia and/or ageusia by employing feature selection techniques to construct a novel variant and gene prioritization pipeline, utilizing machine learning methods for the classification of patients. Models were assessed using a permutation-based variable importance (PVI) strategy for final prioritization of candidate variants and genes. The highest held-out test set area under the receiver operating characteristic (AUROC) curve for models and datasets from the UI cohort was 0.735 and 0.798 for the variant and gene analysis respectively and for the AoU cohort was 0.687 for the variant analysis. Our analysis prioritized several novel and known candidate host genetic factors involved in immune response, neuronal signaling, and calcium signaling supporting previously proposed hypotheses for anosmia/ageusia in COVID-19.
Year:
2024
Collaborators (5)
Richard Smith
Iowa State University
Benjamin Darbro
Professor
The University of Iowa
Kevin T. A. Booth
Clinical Laboratory Director and Assistant Professor
Indiana University School of Medicine
Brian Smith
Professor
Iowa State University
HATEM EL-SHANTI
Iowa State University
Make your next move.
Prepare your application
Review drafts before you send them.